Namita Multani

Toronto, ON, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

18F-Flortaucipir (AV1451) imaging identifies grey matter atrophy in retired athletes.

18F-Flortaucipir (AV1451) imaging identifies grey matter atrophy in retired athletes.

Journal: Journal of neurology

Published: March 10, 2024

Evaluating the Effect of Alzheimer's Disease-Related Biomarker Change in Corticobasal Syndrome and Progressive Supranuclear Palsy.

Evaluating the Effect of Alzheimer's Disease-Related Biomarker Change in Corticobasal Syndrome and Progressive Supranuclear Palsy.

Journal: Annals of neurology

Published: November 13, 2023

Investigating the use of plasma pTau181 in retired contact sports athletes.

Investigating the use of plasma pTau181 in retired contact sports athletes.

Journal: Journal of neurology

Published: February 05, 2022

Progression of neuropsychiatric symptoms in young-onset versus late-onset Alzheimer's disease.

Progression of neuropsychiatric symptoms in young-onset versus late-onset Alzheimer's disease.

Journal: GeroScience

Published: September 10, 2020

Prevalence of Cognitive and Vestibular Impairment in Seniors Experiencing Falls.

Prevalence of Cognitive and Vestibular Impairment in Seniors Experiencing Falls.

Journal: The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques

Published: July 21, 2020

Neurofilament-light in former athletes: a potential biomarker of neurodegeneration and progression.

Neurofilament-light in former athletes: a potential biomarker of neurodegeneration and progression.

Journal: European journal of neurology

Published: March 25, 2020

PET Tau Imaging and Motor Impairments Differ Between Corticobasal Syndrome and Progressive Supranuclear Palsy With and Without Alzheimer's Disease Biomarkers.

PET Tau Imaging and Motor Impairments Differ Between Corticobasal Syndrome and Progressive Supranuclear Palsy With and Without Alzheimer's Disease Biomarkers.

Journal: Frontiers in neurology

Published: March 13, 2020

Assessment of executive function declines in presymptomatic and mildly symptomatic familial frontotemporal dementia: NIH-EXAMINER as a potential clinical trial endpoint.

Assessment of executive function declines in presymptomatic and mildly symptomatic familial frontotemporal dementia: NIH-EXAMINER as a potential clinical trial endpoint.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: January 09, 2020

Nonlinear Z-score modeling for improved detection of cognitive abnormality.

Nonlinear Z-score modeling for improved detection of cognitive abnormality.

Journal: Alzheimer's & dementia (Amsterdam, Netherlands)

Published: December 25, 2019

Vestibular Exercises as a Fall Prevention Strategy in Patients with Cognitive Impairment.

Vestibular Exercises as a Fall Prevention Strategy in Patients with Cognitive Impairment.

Journal: The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques

Published: November 19, 2019

Utility of the global CDR® plus NACC FTLD rating and development of scoring rules: Data from the ARTFL/LEFFTDS Consortium.

Utility of the global CDR® plus NACC FTLD rating and development of scoring rules: Data from the ARTFL/LEFFTDS Consortium.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: July 22, 2019

Individualized atrophy scores predict dementia onset in familial frontotemporal lobar degeneration.

Individualized atrophy scores predict dementia onset in familial frontotemporal lobar degeneration.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: July 06, 2019

Showing 1-12 of 24

Last Updated: 09/26/2026